NYSE:BSX - Boston Scientific Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $47.82
Forecasted Upside: 25.80 %
Number of Analysts: 12
Breakdown:
0 Sell Ratings
1 Hold Ratings
10 Buy Ratings
1 Strong Buy Ratings

^$38.01 As of 07/1/2022 04:59 PM ET

▲ +0.74 (1.99%)

1 month | 3 months | 12 months

Get New Boston Scientific Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for BSX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSX

^$47.82

▲ +25.80% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $47.82, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 25.80% upside from the last price of $38.01.

Current Consensus is Buy

The current consensus among 12 contributing investment analysts is to buy stock in Boston Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

2 strong buy ratings
17 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/11/2021

1 strong buy ratings
15 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/11/2021

1 strong buy ratings
13 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/10/2021

1 strong buy ratings
10 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/8/2021

1 strong buy ratings
10 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/6/2022

1 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/6/2022

1 strong buy ratings
9 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/5/2022

1 strong buy ratings
10 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

7/5/2022

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/29/2022	Canaccord Genuity Group	Lower Price Target	Buy	$51.00 ➝ $43.00	Low
6/29/2022	Canaccord Genuity Group	Lower Price Target	Buy ➝ Buy	$51.00 ➝ $43.00	Low
6/24/2022	BTIG Research	Lower Price Target	Buy	$52.00 ➝ $45.00	Low
5/27/2022	Needham & Company LLC	Upgrade	Hold ➝ Buy	$48.00	Low
5/24/2022	BTIG Research	Reiterated Rating	Buy	$52.00	Low
5/17/2022	Citigroup	Lower Price Target	Buy	$52.00 ➝ $47.00	N/A
4/13/2022	Truist Financial	Initiated Coverage	Buy	$52.00	Low
3/1/2022	Bank of America	Initiated Coverage	Buy ➝ Buy		Medium
2/3/2022	Morgan Stanley	Lower Price Target	Overweight	$53.00 ➝ $51.00	Low
2/3/2022	Raymond James	Lower Price Target	Strong-Buy	$51.00 ➝ $49.00	High
2/3/2022	SVB Leerink	Lower Price Target	Market Perform	$48.00 ➝ $45.00	High
12/21/2021	Truist Financial	Boost Price Target	Buy	$52.00 ➝ $53.00	High
12/9/2021	Royal Bank of Canada	Initiated Coverage	Outperform	$51.00	Low
10/28/2021	Raymond James	Lower Price Target	Strong-Buy	$53.00 ➝ $51.00	Medium
9/21/2021	Morgan Stanley	Reiterated Rating	Buy	$53.00	Medium
7/28/2021	Credit Suisse Group	Boost Price Target	Outperform	$50.00 ➝ $52.00	Low
7/28/2021	Raymond James	Boost Price Target	Strong-Buy	$50.00 ➝ $53.00	Low
7/28/2021	Morgan Stanley	Boost Price Target	Overweight	$51.00 ➝ $53.00	Low
7/15/2021	Needham & Company LLC	Set Price Target	Hold	$42.74	Medium
6/7/2021	Argus	Boost Price Target	Buy	$45.00 ➝ $50.00	Low
5/26/2021	Needham & Company LLC	Downgrade	Buy ➝ Hold		High
5/24/2021	Barclays	Initiated Coverage	Overweight	$51.00	Low
4/29/2021	Truist Financial	Boost Price Target		$42.00 ➝ $50.00	Low
4/29/2021	Morgan Stanley	Boost Price Target	Overweight	$43.00 ➝ $51.00	Low
4/29/2021	Wells Fargo & Company	Boost Price Target	In-Line ➝ Overweight	$42.00 ➝ $50.00	Low
4/29/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$39.00 ➝ $45.00	Low
4/15/2021	Atlantic Securities	Initiated Coverage	Overweight	$52.00	High
2/12/2021	Needham & Company LLC	Boost Price Target	Buy	$43.00 ➝ $46.00	Low
2/4/2021	Raymond James	Boost Price Target	Strong-Buy	$39.00 ➝ $43.00	Low
2/3/2021	Piper Sandler	Boost Price Target	In-Line ➝ Overweight	$46.00 ➝ $48.00	High
2/1/2021	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold		Low
12/15/2020	Morgan Stanley	Boost Price Target	Overweight	$40.00 ➝ $43.00	Low
12/15/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium
12/8/2020	BTIG Research	Reiterated Rating	Buy		Low
11/18/2020	Truist Financial	Lower Price Target		$47.00 ➝ $44.00	Medium
11/18/2020	Smith Barney Citigroup	Lower Price Target		$46.00 ➝ $43.00	High
11/18/2020	Wells Fargo & Company	Lower Price Target	Overweight	$44.00 ➝ $41.00	High
11/18/2020	Morgan Stanley	Lower Price Target	Overweight	$41.00 ➝ $40.00	High
11/17/2020	Needham & Company LLC	Lower Price Target	Buy	$50.00 ➝ $43.00	High
10/29/2020	Morgan Stanley	Lower Price Target	Overweight	$48.00 ➝ $41.00	High
9/17/2020	Truist Financial	Initiated Coverage	Buy	$47.00 ➝ $47.00	High
9/11/2020	Wolfe Research	Initiated Coverage	Market Perform	$46.00	Medium
7/30/2020	Stifel Nicolaus	Boost Price Target	Buy	$45.00 ➝ $47.00	Low
7/30/2020	Jefferies Financial Group	Boost Price Target	Buy	$43.00 ➝ $46.00	Low
7/30/2020	Citigroup	Boost Price Target	Buy	$44.00 ➝ $46.00	Medium
7/30/2020	SVB Leerink	Boost Price Target	Market Perform	$40.00 ➝ $43.00	Medium
7/30/2020	Morgan Stanley	Boost Price Target	Overweight	$45.00 ➝ $48.00	Medium
7/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$50.00	Medium
7/29/2020	Oppenheimer	Boost Price Target	Market Perform	$41.00 ➝ $43.00	Medium
6/24/2020	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	Low
5/13/2020	Argus	Boost Price Target	Buy	$40.00 ➝ $42.00	Low
4/30/2020	CSFB	Boost Price Target	Outperform	$42.00 ➝ $43.00	High
4/30/2020	Wells Fargo & Company	Boost Price Target	Overweight	$40.00 ➝ $41.00	Low
4/30/2020	Credit Suisse Group	Boost Price Target	Outperform	$42.00 ➝ $43.00	Low
4/30/2020	Citigroup	Boost Price Target	Buy	$40.00 ➝ $42.00	Medium
4/30/2020	UBS Group	Lower Price Target	Buy	$50.00 ➝ $45.00	Medium
4/30/2020	Stifel Nicolaus	Boost Price Target	Buy	$35.00 ➝ $45.00	Medium
4/30/2020	Raymond James	Boost Price Target	Strong-Buy	$42.00 ➝ $43.00	High
4/30/2020	Oppenheimer	Reiterated Rating	Hold	$46.00 ➝ $41.00	Low
4/29/2020	BTIG Research	Reiterated Rating	Buy	$44.00	Low
4/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$46.00	Low
4/23/2020	SunTrust Banks	Lower Price Target	Buy	$28.00 ➝ $25.00	Low
4/22/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$40.00	Low
4/9/2020	Raymond James	Lower Price Target	Strong-Buy	$49.00 ➝ $42.00	High
4/2/2020	Piper Sandler	Reiterated Rating	Buy		Low
4/2/2020	Needham & Company LLC	Lower Price Target	Buy	$53.00 ➝ $43.00	Medium
4/1/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Conviction-Buy	$46.00 ➝ $38.00	High
3/27/2020	Citigroup	Lower Price Target	Buy	$48.00 ➝ $40.00	Low
3/24/2020	Stifel Nicolaus	Lower Price Target	Buy	$47.00 ➝ $30.00	High
3/23/2020	Stephens	Lower Price Target	Overweight	$48.00 ➝ $35.00	High
3/9/2020	Cfra	Upgrade	Buy ➝ Strong-Buy	$50.00 ➝ $47.00	Low
3/6/2020	Credit Suisse Group	Lower Price Target	Outperform	$51.00 ➝ $46.00	High
3/4/2020	Citigroup	Initiated Coverage	Buy	$48.00	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$46.00	Low
2/6/2020	BTIG Research	Initiated Coverage	Buy	$46.00	Low
1/15/2020	Cowen	Reiterated Rating	Buy	$52.00	Medium
1/14/2020	Piper Sandler	Reiterated Rating	Buy		Low
12/30/2019	Cowen	Boost Price Target	Outperform	$47.00 ➝ $52.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$50.00 ➝ $55.00	Low
12/19/2019	Needham & Company LLC	Downgrade	Strong-Buy ➝ Buy	$53.00	Low
12/17/2019	Morgan Stanley	Boost Price Target	Overweight	$50.00 ➝ $51.00	Medium
12/16/2019	Wells Fargo & Company	Boost Price Target	Overweight	$48.00 ➝ $52.00	Low
10/25/2019	Guggenheim	Set Price Target	Buy	$53.00	N/A
10/23/2019	Needham & Company LLC	Reiterated Rating	Buy	$53.00	Medium
10/14/2019	Raymond James	Lower Price Target	Strong-Buy	$50.00 ➝ $48.00	Low
9/30/2019	Stephens	Set Price Target	Buy	$48.00	Low
9/6/2019	Stifel Nicolaus	Set Price Target	Buy	$47.00	High
9/5/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight		Medium
9/3/2019	Barclays	Reiterated Rating	Overweight	$48.00	High
8/30/2019	Stifel Nicolaus	Set Price Target	Buy	$46.00	Low
8/29/2019	Morgan Stanley	Set Price Target	Buy	$50.00	Low
7/31/2019	SVB Leerink	Set Price Target	Buy	$50.00	Low
7/25/2019	Raymond James	Boost Price Target	Strong-Buy	$48.00 ➝ $50.00	Medium
7/24/2019	Needham & Company LLC	Set Price Target	Buy	$46.00	Low
7/24/2019	BTIG Research	Set Price Target	Buy	$46.00	Low
7/24/2019	Piper Jaffray Companies	Set Price Target	Buy	$50.00	Low
6/27/2019	Stifel Nicolaus	Boost Price Target	Buy ➝ In-Line	$44.00 ➝ $46.00	Medium
6/27/2019	Jefferies Financial Group	Boost Price Target	Buy ➝ Positive	$44.00 ➝ $48.00	Medium
6/27/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$42.00 ➝ $50.00	Medium
6/18/2019	Wells Fargo & Company	Boost Price Target	Outperform	$42.00 ➝ $45.00	Medium
5/13/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$36.20	Low
5/13/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium
4/25/2019	BTIG Research	Reiterated Rating	Buy		High
2/13/2019	Argus	Boost Price Target	Buy	$43.00 ➝ $45.00	Medium
2/8/2019	SunTrust Banks	Reiterated Rating	Buy	$47.00	Low
2/8/2019	Guggenheim	Reiterated Rating	Buy	$48.00	Low
2/6/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Low
1/8/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$42.00	Low
11/27/2018	UBS Group	Initiated Coverage	Buy ➝ Buy	$45.00	High
11/21/2018	Oppenheimer	Reiterated Rating	Hold		Low
11/21/2018	BTIG Research	Reiterated Rating	Buy		Low
11/20/2018	SunTrust Banks	Boost Price Target	Buy	$44.00	Low
11/19/2018	Stephens	Reiterated Rating	In-Line ➝ Market Perform	$40.00	Medium
11/16/2018	Guggenheim	Boost Price Target	Buy	$45.00	Low
10/26/2018	Argus	Boost Price Target	Buy ➝ Buy	$41.00 ➝ $43.00	Low
10/25/2018	BTIG Research	Reiterated Rating	Buy	$45.00	Medium
10/24/2018	Oppenheimer	Set Price Target	Hold	$38.00	Medium
10/22/2018	Cowen	Set Price Target	Buy	$39.00 ➝ $42.00	Low
10/16/2018	BTIG Research	Reiterated Rating	Buy	$45.00	High
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$43.00	High
10/15/2018	Royal Bank of Canada	Boost Price Target	Top Pick	$42.00	High
10/2/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$38.00 ➝ $48.00	Low
9/25/2018	Oppenheimer	Reiterated Rating	Hold		Medium
9/17/2018	Wells Fargo & Company	Boost Price Target	Outperform	$38.00 ➝ $42.00	Low
9/7/2018	Needham & Company LLC	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$39.00 ➝ $43.00	Low
9/5/2018	Argus	Boost Price Target	Buy	$41.00	Low
9/4/2018	Raymond James	Boost Price Target	Strong-Buy ➝ Strong-Buy	$40.00 ➝ $41.00	Low
9/4/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$34.00 ➝ $42.00	Low
7/27/2018	Guggenheim	Reiterated Rating	Buy	$43.00	Low
7/26/2018	Stifel Nicolaus	Reiterated Rating	Buy	$37.00	Low
7/26/2018	Jefferies Financial Group	Reiterated Rating	Hold	$34.00	Low
7/26/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$33.00 ➝ $38.00	Low
7/26/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$38.00	Low
7/23/2018	Royal Bank of Canada	Boost Price Target	Top Pick	$36.00	Low
7/23/2018	SunTrust Banks	Boost Price Target	Buy	$39.00	Low
7/10/2018	BMO Capital Markets	Boost Price Target	Outperform	$36.00	High
7/6/2018	Needham & Company LLC	Reiterated Rating	Strong-Buy		Medium
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Outperform	$38.00	Low
6/7/2018	Argus	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $36.00	Medium
5/1/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $34.00	Low
4/26/2018	Raymond James	Boost Price Target	Strong-Buy ➝ Strong-Buy	$32.00 ➝ $34.00	Low
4/26/2018	Jefferies Financial Group	Reiterated Rating	Hold	$31.00	Low
4/26/2018	Needham & Company LLC	Boost Price Target	Strong-Buy ➝ Strong-Buy	$35.00 ➝ $36.00	Low
4/26/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$32.00 ➝ $33.00	Low
4/26/2018	JPMorgan Chase & Co.	Boost Price Target	Overweight ➝ Overweight	$31.00 ➝ $32.00	Low
4/5/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$30.00 ➝ $34.00	Low
3/27/2018	Needham & Company LLC	Reiterated Rating	Buy	$35.00	High
3/19/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$30.00 ➝ $33.00	Low
3/5/2018	Royal Bank of Canada	Reiterated Rating	Top Pick	$32.00	Medium
2/23/2018	Piper Jaffray Companies	Initiated Coverage	Overweight ➝ Overweight	$31.00	Medium
2/2/2018	Jefferies Financial Group	Reiterated Rating	Hold ➝ Neutral		Low
1/16/2018	Needham & Company LLC	Reiterated Rating	Buy	$32.00	Low
1/10/2018	Barclays	Reiterated Rating	Buy	$32.00	Low
1/5/2018	Royal Bank of Canada	Upgrade	Outperform ➝ Top Pick		Medium
1/3/2018	Evercore ISI	Initiated Coverage	In ➝ In-Line	$27.00	Medium
12/12/2017	BMO Capital Markets	Reiterated Rating	Buy	$32.00	Low
12/8/2017	Needham & Company LLC	Upgrade	Buy ➝ Strong-Buy	$25.04 ➝ $32.00	Low
12/4/2017	SunTrust Banks	Set Price Target	Buy	$33.00	Low
11/30/2017	Cowen	Set Price Target	Buy	$31.00	Low
11/30/2017	BTIG Research	Upgrade	Neutral ➝ Buy	$31.00	Medium
11/29/2017	BMO Capital Markets	Reiterated Rating	Buy	$31.00	Medium
11/29/2017	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low
11/29/2017	Oppenheimer	Reiterated Rating	Hold		High
11/7/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	N/A
10/31/2017	SunTrust Banks	Set Price Target	Buy	$34.00	N/A
10/27/2017	BMO Capital Markets	Boost Price Target	Outperform	$30.00 ➝ $32.00	N/A
10/13/2017	BMO Capital Markets	Reiterated Rating	Buy	$30.00	N/A
10/3/2017	Needham & Company LLC	Reiterated Rating	Buy	$32.00	Low
10/2/2017	SunTrust Banks	Reiterated Rating	Buy	$34.00	Medium
9/25/2017	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Low
9/7/2017	Jefferies Financial Group	Reiterated Rating	Hold		Low
9/1/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	N/A
8/9/2017	Oppenheimer	Reiterated Rating	Hold		Medium
8/1/2017	UBS Group	Reiterated Rating	Buy	$30.00 ➝ $31.00	Low
7/30/2017	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Medium
7/28/2017	Oppenheimer	Set Price Target	Hold	$29.00	Low
7/28/2017	Cowen	Reiterated Rating	Buy	$31.00 ➝ $32.00	Low
7/17/2017	Cowen	Reiterated Rating	Outperform	$31.00	Low
7/12/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	Low

(Data available from 7/5/2017 forward)

News Sentiment Rating

0.38 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

2 very positive mentions
14 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

12/6/2021

9 very positive mentions
5 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

1/5/2022

4 very positive mentions
23 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

2/4/2022

6 very positive mentions
33 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

3/6/2022

5 very positive mentions
9 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

4/5/2022

5 very positive mentions
32 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

5/5/2022

4 very positive mentions
26 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

6/4/2022

5 very positive mentions
17 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

7/4/2022

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $38.01

$37.09

$38.11

50 Day Range

MA: $39.22

$35.24

$43.06

52 Week Range

Now: $38.01

$34.98

$47.49

Volume

224,386 shs

Average Volume

8,789,882 shs

Market Capitalization

$54.34 billion

P/E Ratio

71.72

Dividend Yield

N/A

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of Boston Scientific?: The following Wall Street analysts have issued reports on Boston Scientific in the last twelve months: Bank of America Co., BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Credit Suisse Group AG, Morgan Stanley, Needham & Company LLC, Raymond James, Royal Bank of Canada, StockNews.com, SVB Leerink LLC, TheStreet, and Truist Financial Co..
View the latest analyst ratings for BSX.
What is the current price target for Boston Scientific?: 0 Wall Street analysts have set twelve-month price targets for Boston Scientific in the last year. Their average twelve-month price target is $47.82, suggesting a possible upside of 25.8%.
View the latest price targets for BSX.
What is the current consensus analyst rating for Boston Scientific?: Boston Scientific currently has 1 hold rating, 10 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BSX will outperform the market and that investors should add to their positions of Boston Scientific.
View the latest ratings for BSX.
What other companies compete with Boston Scientific?: Other companies that are similar to Boston Scientific include Abbott Laboratories, Medtronic, Stryker, Intuitive Surgical, Becton, Dickinson and, Edwards Lifesciences, Baxter International, ResMed, DexCom, IDEXX Laboratories, STERIS, Hologic, Insulet, Teleflex and Abiomed. Learn More about companies similar to Boston Scientific.
How do I contact Boston Scientific's investor relations team?: Boston Scientific's physical mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider's listed phone number is (508) 683-4000 and its investor relations email address is bsxinvesto[email protected] The official website for Boston Scientific is www.bostonscientific.com. Learn More about contacing Boston Scientific investor relations.

NYSE:BSX - Boston Scientific Stock Price Target and Predictions

Analyst Price Target for BSX

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.38 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Boston Scientific?

What is the current price target for Boston Scientific?

What is the current consensus analyst rating for Boston Scientific?

What other companies compete with Boston Scientific?

How do I contact Boston Scientific's investor relations team?